Professional Documents
Culture Documents
Morphology
Egg:
Shape: Oval or elliptical
Size:
Length: 60-75 μm
Width: 35-40 μm
Embryonic cleavage: Two-, four-, or eight-cell stage
Shell: Thin, smooth colorless1
Infective Stage:
L3 or the 3rd stage of larva
Diagnostic Stage:
Unembryonated eggs (pass in feces)
Rhabditiform Larva:
Size: Newly hatched 270 by 15 µm
5 days old: 540-700 µm long
Other features: Long buccal cavity; small genital primordium
Filariform Larva:
Length of esophagus: Short
Tail: Pointed
Adult worm:
Color: Grayish-white to pink
Cuticle: Somewhat thick
Anterior end: Conspicuous bend, hook1
Characteristics
Female Adults
Size 9-12 mm long, 0.25-0.50 mm wide
Male Adults
5-10 mm long, 0.2-0.4 mm wide
Anterior end:
Bent lightly dorsally
Buccal Capsule: contains pair of cutting plates
Posterior end:
Male:
o Expanded in umbrella like fashion
o Bursa
Dorsal ray, deep cleft, bifid tips, spicules fused and barbed
Female:
o Tapering, with no expanded bursa
Genital Opening:
Male: Opens posteriorly with the cloaca
Female: Situated at the junction of posterior and middle 3rd of
body
Habitat
Hosts:
Definitive Host: Human beings
Soil (eggs)
Intermediate Host: None
Transmission:
Via fecal-dermal route (filariform larva penetrates through the skin)2
Life Cycle:
Human Cycle
Lungs Stage
Intestinal Stage
External Environment Cycle2
Human Cycle
Filariform larva penetrate the skin (usually feet or legs)
They are carried by blood to the lungs
Lung stage:
Migrate into alveoli & up the bronchi, trachea
Then are swallowed3
Intestinal Stage:
Develop into adults in the small intestine
Attaching to the wall with cutting plates
Feed on blood from capillaries of the intestinal villi
Thousands of eggs are passed per day in feces3
External Environment Cycle:
Eggs become embryonated in warm, moist soil
Eggs first develop into noninfectious, feeding (rhabditiform) larva
Then into 3rd stage, infectious nonfeeding (filariform) larva
Penetration of larva in the skin completes the cycle3
Pathogenesis:
Loss of blood (0.1 to 0.3ml/worm)
Blood is consumed by the worms
Blood oozes from the site
Epidemiology:
North and South America
This species is also known to exist in China, India, and Africa.4
Clinical Findings:
Mostly asymptomatic
Anemia
Weakness
Pallor
Ground itch
Cutaneous larva migrans
Pneumonia4
Lab Diagnosis:
Direct Fecal Smear
Harada-Mori: allow hatching of larvae from eggs on strips of filter paper with one end immersed
in water. Culture methods are recommended for species identification.
Treatment:
Drugs of Choice
Albendazole 400 mg orally as a single dose
Mebendazole 100 mg orally BID for 3 days or 500 mg as a single dose
Alternative Drug
Pyrantel pamoate 11 mg/kg (maximum dose of 1 g) orally OD for 3 days
Prevention:
Proper disposal of human feces
Avoid walking barefoot (wear shoes)4
Public Health Education
Prognosis:
With proper treatment, the prognosis is excellent